The low-barrier hydrogen bond in enzymic catalysis

被引:42
作者
Cleland, W. W. [1 ,2 ]
机构
[1] Univ Wisconsin, Dept Biochem, Madison, WI 53726 USA
[2] Univ Wisconsin, Inst Enzyme Res, Madison, WI 53726 USA
来源
ADVANCES IN PHYSICAL ORGANIC CHEMISTRY, VOL 44 | 2010年 / 44卷
关键词
LIVER ALCOHOL-DEHYDROGENASE; TRANSITION-STATE ANALOGS; X-RAY CRYSTALLOGRAPHY; HIV-1; PROTEASE; CRYSTAL-STRUCTURE; AB-INITIO; DELTA(5)-3-KETOSTEROID ISOMERASE; MANDELATE RACEMASE; CARBOXYPEPTIDASE-A; CYTIDINE DEAMINASE;
D O I
10.1016/S0065-3160(08)44001-7
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
This chapter describes the various aspects of the low-barrier hydrogen bond in enzymic catalysis. Hydrogen bonds come in a continuum of bond lengths and strengths. The first examples of enzymatic reactions where low-barrier hydrogen bonds played a role involved enolization of the substrate to change the pK of a key group in the reaction. Mandelate racemase enolizes R or S mandelate to convert the carboxyl group into an aci-carboxylate, which can be protonated on opposite sides to give the R or S forms. A low-barrier hydrogen bond forms between Asp102 and His57 in the tetrahedral intermediate of the reaction catalyzed by chymotrypsin and similar serine proteases. Phospholipase A2 catalyzes the hydrolysis of phospholipids at the sn-2 bond, using a water molecule coordinated to Ca2+. Enzymes from bovine pancreas and bee venom are similar in many respects and both contain anaspartate and histidine as catalytic groups. In the presence of phosphonate inhibitors that mimic a tetrahedral intermediate, a low-barrier hydrogen bond exists between the histidine and phosphonate oxygen, whereas the hydrogen bond between the histidine and aspartate is a normal one. A general acid–base catalysis provides a five orders of magnitude rate of acceleration in enzymatic reactions, which is consistent with the energy provided by forming a low-barrier hydrogen bond in the transition state. © 2010 Elsevier Ltd
引用
收藏
页码:1 / 17
页数:17
相关论文
共 61 条
[1]   BIHYDROXIDE (H3O2-) ANION - VERY SHORT, SYMMETRIC HYDROGEN-BOND [J].
ABUDARI, K ;
RAYMOND, KN ;
FREYBERG, DP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1979, 101 (13) :3688-3689
[2]   Catalytically important ionizations along the reaction pathway of yeast pyrophosphatase [J].
Belogurov, GA ;
Fabrichniy, IP ;
Pohjanjoki, P ;
Kasho, VN ;
Lehihuhta, E ;
Turkina, MV ;
Cooperman, BS ;
Goldman, A ;
Baykov, AA ;
Lahti, R .
BIOCHEMISTRY, 2000, 39 (45) :13931-13938
[3]   A phenylnorstatine inhibitor binding to HIV-1 protease: Geometry, protonation, and subsite-pocket interactions analyzed at atomic resolution [J].
Brynda, J ;
Rezacova, P ;
Fabry, M ;
Horejsi, M ;
Stouracova, R ;
Sedlacek, J ;
Soucek, M ;
Hradilek, M ;
Lepsik, M ;
Konvalinka, J .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (08) :2030-2036
[4]   A new concept for the mechanism of action of chymotrypsin: The role of the low-barrier hydrogen bond [J].
Cassidy, CS ;
Lin, J ;
Frey, PA .
BIOCHEMISTRY, 1997, 36 (15) :4576-4584
[5]   Low-barrier hydrogen bonds and enzymatic catalysis [J].
Cleland, WW .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 382 (01) :1-5
[6]   LOW-BARRIER HYDROGEN-BONDS AND LOW FRACTIONATION FACTOR BASES IN ENZYMATIC-REACTIONS [J].
CLELAND, WW .
BIOCHEMISTRY, 1992, 31 (02) :317-319
[7]   LOW-BARRIER HYDROGEN-BONDS AND ENZYMATIC CATALYSIS [J].
CLELAND, WW ;
KREEVOY, MM .
SCIENCE, 1994, 264 (5167) :1887-1890
[8]   The low barrier hydrogen bond in enzymatic catalysis [J].
Cleland, WW ;
Frey, PA ;
Gerlt, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (40) :25529-25532
[9]   A neutron laue diffraction study of endothiapepsin: Implications for the aspartic proteinase mechanism [J].
Coates, L ;
Erskine, PT ;
Wood, SP ;
Myles, DAA ;
Cooper, JB .
BIOCHEMISTRY, 2001, 40 (44) :13149-13157
[10]   The catalytic mechanism of an aspartic proteinase explored with neutron and X-ray diffraction [J].
Coates, Leighton ;
Tuan, Han-Fang ;
Tomanicek, Stephen ;
Kovalevsky, Andrey ;
Mustyakimov, Marat ;
Erskine, Peter ;
Cooper, Jon .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (23) :7235-+